急性脑损伤后阵发性交感神经过度兴奋患者的诊断与管理:基于共识诊断工具的单中心病例系列
本文报告单中心三级医院内科与外科ICU 2015年4月至2017年3月间,521例急性脑损伤(包括创伤性脑损伤、卒中、感染性疾病和脑病,无论意识是否改变)患者中394例存活者,用PSH-AM诊断出6例(1.5%)阵发性交感神经过度兴奋(PSH)。PSH-AM由两部分组成:基于PSH临床特征的诊断可能性工具,以及赋予每种交感过度兴奋严重度的临床特征量表。作者认为PSH-AM是ICU中PSH管理的有用评分系统,可用于早期客观诊断、严重度评估和序贯疗效评价,并认为重症医生应考虑PSH可能并使用PSH-AM作为诊断和管理指导工具。
要点
- 在394例急性脑损伤ICU存活者中,用PSH-AM诊断出6例(1.5%)PSH,提示该病在ICU中并不常见但需识别。
- PSH-AM由诊断可能性工具(基于PSH临床特征)和临床特征量表(赋予每种交感过度兴奋严重度)两部分组成。
- PSH表现为发作性短暂发热、心动过速、高血压、呼吸急促、大量出汗和特定姿势。
- ICU中并存疾病常模仿PSH,是导致PSH诊断陷阱和认识不足的重要原因。
- 作者认为PSH-AM可用于PSH的早期客观诊断、严重度评估和序贯治疗疗效评价。
适用人群与场景
- 急性脑损伤患者,定义为任何严重程度的急性脑损伤,无论是否存在意识改变,包括创伤性脑损伤、卒中、感染性疾病和脑病。
- 场景为三级医院内科与外科ICU,时间为2015年4月至2017年3月。
诊断标准与关键阈值
- PSH-AM共识诊断标准由两部分组成:诊断可能性工具(基于PSH临床特征)和临床特征量表(赋予每种交感过度兴奋的严重度)。
红旗征与不能漏的情况
- PSH表现为发作性短暂发热、心动过速、高血压、呼吸急促、大量出汗和特定姿势。
- ICU中并存疾病高发,常模仿PSH,导致诊断陷阱和认识不足。
研究设计与关键结果
- 单中心病例系列:521例急性脑损伤患者中394例存活,其中6例(1.5%)通过PSH-AM诊断为PSH。
- PSH-AM在ICU的PSH管理中作为有用的评分系统,用于早期客观诊断、严重度评估和序贯治疗疗效评价。
证据类型、等级与局限
- 证据类型:单中心病例系列。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为重症医生应考虑PSH的可能性,并可将PSH-AM用作PSH管理中的有用诊断和指导工具。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Paroxysmal sympathetic hyperactivity (PSH) is a distinct syndrome of episodic sympathetic hyperactivities following severe acquired brain injury, characterized by paroxysmal transient fever, tachycardia, hypertension, tachypnea, excessive diaphoresis and specific posturing. PSH remains to be an under-recognized condition with a diagnostic pitfall especially in the intensive care unit (ICU) settings due to the high prevalence of concomitant diseases that mimic PSH. A consensus set of diagnostic criteria named PSH-Assessment Measure (PSH-AM) has been developed recently, which is consisted of two components: a diagnosis likelihood tool derived from clinical characteristics of PSH, and a clinical feature scale assigned to the severity of each sympathetic hyperactivity. We herein present a case series of patients with PSH who were diagnosed and followed by using PSH-AM in our tertiary institutional medical and surgical ICU between April 2015 and March 2017 in order to evaluate the clinical efficacy of PSH-AM. Among 394 survivors of 521 patients admitted with acquired brain injury defined as acute brain injury at all levels of severity regardless of the presence of altered consciousness, including traumatic brain injury, stroke, infectious disease, and encephalopathy, 6 patients (1.5%) were diagnosed as PSH by using PSH-AM. PSH-AM served as a useful scoring system for early objective diagnosis, assessment of severity, and serial evaluation of treatment efficacy in the management of PSH in the ICU settings. In conclusion, critical care clinicians should consider the possibility of PSH and can use PSH-AM as a useful diagnostic and guiding tool in the management of PSH.
参考来源
- Godo S, Irino S, Nakagawa A, et al. Diagnosis and Management of Patients with Paroxysmal Sympathetic Hyperactivity following Acute Brain Injuries Using a Consensus-Based Diagnostic Tool: A Single Institutional Case Series. Tohoku J Exp Med. 2017. PMID: 28890524. doi:10.1620/tjem.243.11
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。